The Journal of Pediatrics
Volume 152, Issue 4 , Pages 458-466 , April 2008

Primary Care Management of the Childhood Cancer Survivor

  • Beth A. Kurt, MD

      Affiliations

    • Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Gregory T. Armstrong, MD

      Affiliations

    • Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Darlene Kaye Cash, MD

      Affiliations

    • Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Matthew J. Krasin, MD

      Affiliations

    • Department of Radiological Sciences, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • E. Brannon Morris, MD

      Affiliations

    • Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Sheri L. Spunt, MD

      Affiliations

    • Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Leslie L. Robison, PhD

      Affiliations

    • Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN.
    • ,
  • Melissa M. Hudson, MD

      Affiliations

    • Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN.
    • Corresponding Author InformationReprint requests: Melissa M. Hudson, MD, St. Jude Children’s Research Hospital, 332 North Lauderdale, Mailstop 735, Memphis, TN 38105.

Received 15 June 2007 ,Revised 30 July 2007 ,Accepted 1 October 2007.

References 

  1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66
  2. Eiser C, Vance YH. Implications of cancer for school attendance and behavior. Med Pediatr Oncol. 2002;38:317–319
  3. Moore BD. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol. 2005;30:51–63
  4. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399–408
  5. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil. 2004;7:1–14
  6. Mitby PA, Robison LL, Whitton JA, Zevon MA, Gibbs IC, Tersak JM, et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003;97:1115–1126
  7. Kushner BH, Budnick A, Kramer K, Modak S, Cheung NK. Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma. Cancer. 2006;107:417–422
  8. Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23:8588–8596
  9. Oberfield SE, Sklar CA. Endocrine sequelae in survivors of childhood cancer. Adolesc Med. 2002;13:161–169
  10. Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998;83:3121–3129
  11. Wi JM, Boersma B. Catch-up growth: definition, mechanisms, and models. J Pediatr Endocrinol Metab. 2002;15(Suppl 5):1229–1241
  12. Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 2.0, updated March 2006. www.survivorshipguidelines.orgAccessed July 28, 2007
  13. Rose S. Endocrinopathies in childhood cancer survivors. Endocrinologist. 2003;13:488–495
  14. Gleeson HK, Shalet SM. The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocr Relat Cancer. 2004;11:589–602
  15. Roth C, Lakomek M, Schmidberger H, Jarry H. Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone. Klin Pediatr. 2001;213:239–243[in German]
  16. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003;21:1359–1365
  17. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611–616
  18. Gurney JG, Ness KK, Sibley SD, O’Leary M, Dengel DR, Lee JM, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006;107:1303–1312
  19. Kaste SC. Bone-mineral density deficits from childhood cancer and its therapy: a review of at-risk patient cohorts and available imaging methods. Pediatr Radiol. 2004;34:373–378
  20. Kaste S, Hopkins K, Jones D, Crom D, Greenwald C, Santana V. Dental abnormalities in children treated for acute lymphoblastic leukemia. Leukemia. 1997;11:792–796
  21. Kaste SC, Hopkins KP, Bowman LC, Santana VM. Dental abnormalities in children treated for neuroblastoma. Med Pediatr Oncol. 1998;30:22–27
  22. Sklar C. Reproductive physiology and treatment-related loss of sex hormone production. Med Pediatr Oncol. 1999;33:2–8
  23. Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med. 1987;317:1315–1321
  24. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst. 2006;98:890–896
  25. Adams M, Lipshultz SE. Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention. Pediatr Blood Cancer. 2005;44:600–606
  26. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voute PA. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol. 2002;13:819–829
  27. Kreisman H, Wolkove N. Pulmonary toxicity of antineoplastic therapy. Semin Oncol. 1992;19:508–520
  28. Hudson M. Survivors of Childhood and Adolescent Cancer. In:  Schwartz C,  Hobbie W,  Constine L,  Ruccione K editor. Late gastrointestinal and hepatic effects. Heidelberg, Germany: Springer; 2005;p. 181–202
  29. Broxson EH, Dole M, Wong R, Laya BF, Stork L. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy. Pediatr Blood Cancer. 2005;44:226–231
  30. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31:1249–1256
  31. Skinner R, Sharkey IM, Pearson AD, Craft AW. Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol. 1993;11:173–190
  32. Stohr W, Paulides M, Bielack S, Jurgens H, Koscielniak E, Rossi R, et al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer. 2007;48:140–147
  33. Marks L, Larrier N. Survivors of Childhood and Adolescent Cancer. In:  Schwartz C,  Hobbie W,  Constine L,  Ruccione K editor. Genitourinary. Heidelberg, Germany: Springer; 2005;p. 231–242
  34. English MW, Skinner R, Pearson AD, Price L, Wyllie R, Craft AW. Dose-related nephrotoxicity of carboplatin in children. Br J Cancer. 1999;81:336–341

 Supported in part by Cancer Center Support (CORE) grant CA 21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC).

PII: S0022-3476(07)00958-4

doi: 10.1016/j.jpeds.2007.10.002

The Journal of Pediatrics
Volume 152, Issue 4 , Pages 458-466 , April 2008

Article Tools